Laboratory Medicine ›› 2019, Vol. 34 ›› Issue (5): 476-478.DOI: 10.3969/j.issn.1673-8640.2019.05.021
Received:2018-08-18
Online:2019-05-30
Published:2019-05-28
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2019.05.021
| 细胞群 | 百分比（%） | 细胞系/表型分析 |
|---|---|---|
| 淋巴细胞 | 6.7 | T细胞占淋巴细胞的65.9%,CD4∶CD8=1.52,未见明显异常;自然杀伤细胞占淋巴细胞的14.5%,未见明显异常;成熟B细胞占淋巴细胞的6.1%,多为克隆B细胞 |
| 粒细胞 | 22.2 | 相对比例减小 |
| 单核细胞 | 4.6 | 未见明显异常 |
| CD45弱表达细胞 | 5.9 | 主要为原始/幼稚髓系细胞 |
| CD45阴性表达细胞 | 60.6 | 主要为表达巨核系免疫表型的细胞群及少量细胞碎片 |
| 细胞群 | 百分比（%） | 细胞系/表型分析 |
|---|---|---|
| 淋巴细胞 | 6.7 | T细胞占淋巴细胞的65.9%,CD4∶CD8=1.52,未见明显异常;自然杀伤细胞占淋巴细胞的14.5%,未见明显异常;成熟B细胞占淋巴细胞的6.1%,多为克隆B细胞 |
| 粒细胞 | 22.2 | 相对比例减小 |
| 单核细胞 | 4.6 | 未见明显异常 |
| CD45弱表达细胞 | 5.9 | 主要为原始/幼稚髓系细胞 |
| CD45阴性表达细胞 | 60.6 | 主要为表达巨核系免疫表型的细胞群及少量细胞碎片 |
| [1] | NIINO D,TSUCHIYA T,TOMONAGA M,et al.Clinicopathological features of acute megakaryoblastic leukaemia:relationship between fibrosis and platelet-derived growth factor[J]. Pathol Int,2013,63(3):141-149. |
| [2] | HEHLMANN R,SAUSSELE S.Treatment of chronic myeloid leukemia in blast crisis[J]. Haematologica,2008,93(12):1765-1769. |
| [3] | PAGANO L,PULSONI A,VIGNETTI M,et al.Acute megakaryoblastic leukemia:experience of GIMEMA trials[J]. Leukemia,2002,16(9):1622-1626. |
| [4] | AL-SHEHRI A,AL-SERAIHY A,OWAIDAH T M,et al.Megakaryocytic blast crisis at presentation in a pediatric patient with chronic myeloid leukemia[J]. Hematol Oncol Stem Cell Ther,2010,3(1):42-46. |
| [5] | BHATTACHARYA J B,GUPTA R,SAMADHIYA A.Acute megakaryoblastic blast crisis as a presentation manifestation of chronic myelogenous leukemia[J]. Blood Res,2017,52(2):137-139. |
| [6] | PARK S H,CHI H S,CHO Y U,et al.Two cases of myeloproliferative neoplasm with a concurrent JAK2 (V617F) mutation and BCR/ABL translocation without chronic myelogenous leukemia phenotype acquisition during hydroxyurea treatment[J]. Ann Lab Med,2013,33(3):229-232. |
| [1] | FAN Lieying. Research status and application prospects of biomarkers for membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1111-1114. |
| [2] | SUN Lincheng, LI Jianfeng, CHENG Weili, JI Panyun. Roles of anti-PLA2R IgG4 antibody and PLA2R IgG4/IgG ratio in primary membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1115-1120. |
| [3] | LIU Qingyang, YUAN Jianming, XIA Jinjun, JIANG Fengying, WANG Qiubo, WANG Xiaoming. CXCL9 as a potential diagnostic marker of rheumatoid arthritis based on GEO database and experimental verification [J]. Laboratory Medicine, 2023, 38(12): 1121-1129. |
| [4] | YANG Xiao, LI Enling, WU Lixia, DAI Yingxin, WANG Zhiqing, HUANG Hao, ZHENG Bing. Influence of cytoplasmic antinuclear antibody on indirect immunofluorescence assay based antineutrophil cytoplasmic antibody determination [J]. Laboratory Medicine, 2023, 38(12): 1135-1140. |
| [5] | XIANG Jin, LIU Aiping, HU Yao, WU Zhiyuan, CAO Guojun, GUAN Ming. ANA profiles in COVID-19 patients and influence of serum heat-inactivation on ANA determination [J]. Laboratory Medicine, 2023, 38(12): 1141-1146. |
| [6] | CHENG Yu, XU Zhen, LU Liu, DING Menglei, YU Shanshan, ZONG Ming, FAN Lieying. Expression and risk factors of anti-ACE-2 antibody in serum of patients with COVID-19 [J]. Laboratory Medicine, 2023, 38(12): 1147-1152. |
| [7] | . [J]. Laboratory Medicine, 2023, 38(12): 1153-1156. |
| [8] | . [J]. Laboratory Medicine, 2023, 38(12): 1157-1159. |
| [9] | WANG Hongling, LIU Mengna, BAI Ping, LIAO Huanjin. Risk factors of relapse following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia [J]. Laboratory Medicine, 2023, 38(12): 1160-1166. |
| [10] | YANG Xilan, WANG Jinyu, LIU Shuyu, ZHAN Yiyang, LIU Jing, JIA Jian. Correlation between hyperlipidemia and endothelial microparticles in elderly patients from Gulou Community in Nanjing [J]. Laboratory Medicine, 2023, 38(12): 1167-1172. |
| [11] | DAI Fangfang, LU Xinxin, YU Yanhua, CHEN Ming, SUN Guizhen. Analysis of Mycobacterium infection in HIV/AIDS patients [J]. Laboratory Medicine, 2023, 38(12): 1173-1176. |
| [12] | GU Yu, LIANG Xiaoyan, MA Shenghui, TONG Na, CHENG Mingyan, YAN Zejun. Expression and near-term prognostic predictive value of plasma biomarkers in chronic kidney disease patients with thromboembolism [J]. Laboratory Medicine, 2023, 38(12): 1177-1182. |
| [13] | . [J]. Laboratory Medicine, 2023, 38(12): 1183-1185. |
| [14] | . [J]. Laboratory Medicine, 2023, 38(12): 1186-1190. |
| [15] | . [J]. Laboratory Medicine, 2023, 38(12): 1191-1194. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
